Union minister of State Dr. Jitendra Singh launched Phase III of the Biomedical Research Career Programme (BRCP) with a total outlay of Rs. 1,500 crore. The initiative aims to strengthen biomedical research, develop scientific talent, and enhance India’s global leadership in biotechnology and healthcare innovation.
Funding Structure of BRCP Phase III
The programme is being funded through a public-private partnership model. The partnership reflects growing international confidence in India’s biomedical research ecosystem and its potential to drive scientific breakthroughs. Dr. Singh described biotechnology as a key driver of the emerging global knowledge economy. He emphasized that advances in biotechnology are increasingly shaping healthcare innovation, industrial development, economic policy and national development strategies. The government views biomedical research as a strategic sector for long-term economic and technological growth.
India’s Bioeconomy Shows Rapid Expansion
The Minister highlighted the remarkable growth of India’s bioeconomy over the past decade. He also noted that India has developed a robust biotechnology ecosystem with nearly 12,000 startups and has emerged as one of the world’s leading vaccine manufacturers. BRCP Phase III is designed to create a stronger pipeline of biomedical researchers and innovators. The programme will support advanced biomedical research projects, scientific talent development, translational research initiatives, international research collaborations and innovation in healthcare and biotechnology. The initiative aims to help Indian researchers compete at the global level and contribute to cutting-edge discoveries in medicine, diagnostics, vaccines, and biotechnology.
Strengthening India’s Global Scientific Leadership
With the launch of BRCP Phase III, the government intends to accelerate India’s transition from a growing biotechnology market to a global leader in biomedical research and innovation. As reported by projectstoday.ai, by combining substantial public investment with international collaboration, the programme is expected to strengthen research infrastructure, attract high-quality scientific talent, and support the development of next-generation healthcare technologies.
